General or non-medical topics with information and discussion related to Lyme disease and other tick-borne diseases.
-
X-member
- Posts: 9899
- Joined: Mon 30 Jul 2007 18:18
Post
by X-member » Fri 4 Dec 2015 13:03
NordTick 2016
http://xn--flttsenteret-ucb.no/2015/11/nortick-2016/
A quote:
In 2016, The Norwegian Tick Research Network (NorTick) has joined the Swedish tick research network SNÄFF (Sveriges Nätverk av Fästing Forskare) - arranging NordTick - a Nordic conference on Ticks and Tick-borne diseases that will bring together the leading scientists of that field in Norway, Denmark, Sweden and Finland.
The 2016 conference will consist of four scientific sessions covering different aspects of tick-borne diseases.
1. Tick biology and ecology.
2. Borrelia – microbiology, clinics (diagnostics, treatment, prevention), pathogenisis
3. Other tick-borne baceterial pathogens and parasites (e.g. Anaplasma, Rickettsia, Neoerlichia, Babesia)
4. TBEV and other tick-borne viruses.
-
Stella
- Posts: 7
- Joined: Fri 11 Feb 2011 15:38
- Location: UK
-
Contact:
Post
by Stella » Thu 28 Jan 2016 16:13
Lyme Disease Action is presenting a poster at this conference. "Lyme Borreliosis, A model for improved diagnosis". We will put the poster on our website next week after the conference. See also
https://twitter.com/LymeAction
We describe a process we have managed to start in the UK but we anticipate that many of the microbiologists and ID doctors will disagree with us. It works, but because we have few resources it only helps a few. Doctors who engage, though, learn something out of it, so we hope the effect ripples outwards.
Stella
-
X-member
- Posts: 9899
- Joined: Mon 30 Jul 2007 18:18
Post
by X-member » Wed 24 Feb 2016 0:01
NordTick 2016 Conference
http://www.lymediseaseaction.org.uk/lat ... onference/
A quote:
Dag Nyman from the Åland Group for Borrelia Research, in his talk on Diagnostics of neuroborreliosis argued that the case definitions in the European EFNS guidelines for LNB should be abandoned as they depend heavily on clinical findings and serology, leaving many ‘possible’ cases who then seek treatment elsewhere. They use CXCL13 in spinal fluid to help improve diagnosis.